Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice
about
Cul4A is required for hematopoietic cell viability and its deficiency leads to apoptosisMolecular signatures of quiescent, mobilized and leukemia-initiating hematopoietic stem cells.The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling.Lyn- and PLC-beta3-dependent regulation of SHP-1 phosphorylation controls Stat5 activity and myelomonocytic leukemia-like disease.The epigenetic regulator CXXC finger protein 1 is essential for murine hematopoiesis.Deficiency of β Common Receptor Moderately Attenuates the Progression of Myeloproliferative Neoplasm in NrasG12D/+ Mice.Targeting oncogenic Ras signaling in hematologic malignancies.Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor gene.Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesisStat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiencyThe granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease.Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates.Long-term serial xenotransplantation of juvenile myelomonocytic leukemia recapitulates human disease in Rag2-/-γc-/- mice.Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk.PLC-γ and PI3K link cytokines to ERK activation in hematopoietic cells with normal and oncogenic Kras
P2860
Q28593134-E724B633-028C-4682-962D-D6C1AFBD19D5Q33526322-CBD0FAE7-CBFB-4F42-A98D-784B20619358Q34304678-75C2DE86-15EA-4354-BC5E-3E368868C4AEQ34541593-91EF400C-889A-43DD-AAD2-3D437A8F8A13Q34625800-66DE2DD1-E432-4359-84F8-B845EEC2E11AQ35905350-A557F3B1-7B67-4F3D-9E8C-20C102C05A9BQ36352506-38A38C5C-566F-4DB8-A679-B67685499D62Q36407371-D301BF58-80F2-42AC-A570-260BF53ED759Q37081986-E8E31E0D-BC85-47E6-9B6C-9FC3F3448679Q37176577-C03E0003-9C30-43CC-BFB3-1F860A00AD11Q37304113-910D4A01-C085-48A2-9ABF-643E792AE2C4Q37306641-F7384C06-E3FD-4ED8-B77B-D945FC3FAF32Q40039203-905342CE-714B-4710-8CDF-95B6B306C5FEQ40903923-7C7B33D7-9B80-4C66-9CE2-4486AA98A46FQ42438728-43445C80-0751-4ED4-B101-B748C03B1470Q42760471-64E78DF4-3650-4B08-85F4-653F21339B0A
P2860
Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Beta common receptor inactivat ...... ive disease in Nf1 mutant mice
@ast
Beta common receptor inactivat ...... ive disease in Nf1 mutant mice
@en
type
label
Beta common receptor inactivat ...... ive disease in Nf1 mutant mice
@ast
Beta common receptor inactivat ...... ive disease in Nf1 mutant mice
@en
prefLabel
Beta common receptor inactivat ...... ive disease in Nf1 mutant mice
@ast
Beta common receptor inactivat ...... ive disease in Nf1 mutant mice
@en
P2093
P2860
P1433
P1476
Beta common receptor inactivat ...... ive disease in Nf1 mutant mice
@en
P2093
Andrew Kim
David A Largaespada
Diane E Hasz
Jennifer L Geurts
Jennifer O Lauchle
Kelly Morgan
Kevin Shannon
Luis F Parada
Miechaleen D Diers
P2860
P304
P356
10.1182/BLOOD-2006-05-025395
P407
P577
2006-11-07T00:00:00Z